Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Nature Reviews. Rheumatology|March 4, 2010
Therapy: Assessing cancer risk of cytokine inhibitors in RAAnja Strangfeld, Angela Zink
Best Practice & Research. Clinical Rheumatology|November 28, 2006
Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapyAnja Strangfeld, Joachim Listing
Zeitschrift Fur Rheumatologie|October 20, 2025
[New results from the RABBIT register on the cancer risk of patients with rheumatoid arthritis treated with Janus kinase inhibitors]Martin Schäfer, Anja Strangfeld
Zeitschrift Fur Rheumatologie|September 18, 2021
[Insights into pregnancy and breastfeeding in inflammatory rheumatic diseases through observational data]Yvette Meißner, Anja Strangfeld
Zeitschrift Fur Rheumatologie|May 28, 2026
Martin Schäfer, Anja Strangfeld
Zeitschrift Fur Rheumatologie|December 23, 2021
[Latest findings from the RABBIT register]Yvette Meißner, Anja Strangfeld
Innere Medizin (Heidelberg, Germany)|March 6, 2023
[Gender-specific differences in the diagnosis and treatment of inflammatory rheumatic diseases]Katinka Albrecht, Anja Strangfeld
Deutsche Medizinische Wochenschrift (1946)|August 3, 2021
[Risk profile of disease-modifying antirheumatic drugs: an update from the RABBIT register]Katinka Albrecht, Anja Strangfeld
Current Opinion in Rheumatology|February 2, 2018
Rheumatoid arthritis treatment in patients with a history of cancerAnne C Regierer, Anja Strangfeld
Annals of the Rheumatic Diseases|July 3, 2020
Methotrexate: what are the true risks of treatment?Anja Strangfeld, Gerd R Burmester
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Nature Reviews. Rheumatology|March 4, 2010
Therapy: Assessing cancer risk of cytokine inhibitors in RAAnja Strangfeld, Angela Zink
Best Practice & Research. Clinical Rheumatology|November 28, 2006
Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapyAnja Strangfeld, Joachim Listing
Zeitschrift Fur Rheumatologie|October 20, 2025
[New results from the RABBIT register on the cancer risk of patients with rheumatoid arthritis treated with Janus kinase inhibitors]Martin Schäfer, Anja Strangfeld
Zeitschrift Fur Rheumatologie|September 18, 2021
[Insights into pregnancy and breastfeeding in inflammatory rheumatic diseases through observational data]Yvette Meißner, Anja Strangfeld
Zeitschrift Fur Rheumatologie|May 28, 2026
Martin Schäfer, Anja Strangfeld
Zeitschrift Fur Rheumatologie|December 23, 2021
[Latest findings from the RABBIT register]Yvette Meißner, Anja Strangfeld
Innere Medizin (Heidelberg, Germany)|March 6, 2023
[Gender-specific differences in the diagnosis and treatment of inflammatory rheumatic diseases]Katinka Albrecht, Anja Strangfeld
Deutsche Medizinische Wochenschrift (1946)|August 3, 2021
[Risk profile of disease-modifying antirheumatic drugs: an update from the RABBIT register]Katinka Albrecht, Anja Strangfeld
Current Opinion in Rheumatology|February 2, 2018
Rheumatoid arthritis treatment in patients with a history of cancerAnne C Regierer, Anja Strangfeld
Annals of the Rheumatic Diseases|July 3, 2020
Methotrexate: what are the true risks of treatment?Anja Strangfeld, Gerd R Burmester
Pageof 13